The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

Clinical trials are in progress to see how this therapy might be able to treat other types of cancers, including solid tumors, which can be harder for CAR T-cells to reach. Monoclonal antibody ...

Phase 3 trial results GSK5764227 (GSK) Antibody-drug conjugate composed of a fully human anti-B7-H3 monoclonal antibody covalently linked to a topoisomerase inhibitor payload Treatment of relapsed ...